Amarin Corp Plc (AMRN)

[dmlcento]

https://www.fda.gov/drugs/generic-drugs/what-approval-process-generic-drugs

I don't see anything in this FDA write-up that says that a generic drug has to address an unmet need. I do, however, see that there is a requirement that the container the drug is delivered in must be appropriate. I thought that Amarin has a patent for its encapsulation method. If so, is there a way that the FDA halts this due to the capsule being suggested or used by the generics?